Strumento inattivo

Altre lingue Zogenix, Inc. Nasdaq

Azioni

US98978L1052

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Pulmocide Announces Expansion of Management Team	08/06/23
Oncolytics Biotech Appoints Jonathan Rigby to its Board of Directors	08/09/22
UCB updates financial guidance for 2022 while maintaining 2025 financial guidance	27/06/22
Zogenix Inc. - FINTEPLA (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)	29/03/22
Degroof Petercam verhoogt koersdoel UCB	28/03/22
groen licht Fintepla goed nieuws voor UCB	28/03/22
U.S. FDA approves UCB's drug for rare childhood epilepsy	28/03/22
UBS haalt UCB van verkooplijst	23/03/22
Kepler Cheuvreux verhoogt koersdoel UCB aanzienlijk	21/03/22
Bel20 weet herstel net vast te houden	08/03/22
Bel20 herstelt	08/03/22
Bel20 herstelt	08/03/22
Brussel vrijwel onveranderd van start	08/03/22
Zogenix Completes $1.9 Billion Buyout by UCB; Shares Delisted From Nasdaq	07/03/22
UCB Closes Zogenix Acquisition for Nearly $1.9 Billion	07/03/22
UCB rondt overname Zogenix af	07/03/22
UCB Completes Acquisition of Zogenix, Inc.	07/03/22
ZOGENIX, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	07/03/22
Zogenix To Present New Long-term Data on FINTEPLA (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022	07/03/22
Zogenix : Amendment to Annual Report (Form 10-K/A)	07/03/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zogenix, Inc. Nasdaq

Azioni

US98978L1052

Altre lingue

Filtri